Rockefeller Capital Management L.P.

Position in ARVN — Arvinas, Inc.

CIK 1739439 NEW YORK, NY

Position in ARVN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,490

-$56,559 QoQ

Shares Held

420

-92.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#175

of 198 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rockefeller Capital Management L.P. holds $307,135,851 across 241 Biotechnology names. ARVN ranks #191 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	149,476	$74,249,211
2	JAZZ	Jazz Pharmaceuticals plc	167,409	$40,340,545
3	ACAD	Acadia Pharmaceuticals Inc	1,015,420	$25,690,124
4	BMRN	Biomarin Pharmaceutical Inc	433,376	$24,797,774
5	PTCT	Ptc Therapeutics, Inc.	302,393	$24,666,195
6	MDGL	Madrigal Pharmaceuticals, Inc.	29,015	$15,579,603
7	REGN	Regeneron Pharmaceuticals, Inc.	21,563	$13,445,391
8	CORT	Corcept Therapeutics Inc	123,388	$10,728,585

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,490	420	-92.6%	Shares	Defined	2026-08-13
2026-03-31	$60,049	5,665	-7.1%	Shares	Defined	2026-05-14
2025-12-31	$72,310	6,097	0.0%	Shares	Defined	2026-03-17
2025-09-30	$51,946	6,097	+176.9%	Shares	Defined	2025-11-14
2022-12-31	$75,330	2,202	+9.0%	Shares	Defined	2023-03-06
2022-09-30	$89,869	2,020	0.0%	Shares	Defined	2022-11-02
2022-06-30	$85,021	2,020	+0.1%	Shares	Defined	2022-08-12
2022-03-31	$135,811	2,018	+0.4%	Shares	Defined	2022-05-13
2021-12-31	$165,101	2,010	+0.5%	Shares	Defined	2022-02-14
2021-09-30	$164,360	2,000	-0.5%	Shares	Defined	2021-11-12
2021-06-30	$154,847	2,011	+101.1%	Shares	Defined	2021-08-10
2021-03-31	$66,100	1,000	—	Shares	Defined	2021-05-11
No filing history on record for this holder in this stock.